Today's stock picks by Brooke Thackray and The Weekly Buzzing Stocks by Billy Kawasaki are AAPL-Q, BA-N, T-N, XLV-N, XLU-N, HTB-T.
Another defensive name that is good for investors. A.I. demand along with Bitcoin driving need for energy. Large energy suppliers are seeing record growth. Expecting upward trend to continue. Falling interest rates will be good for utility balance sheets.
Yield curve indicating that interest rates are expecting. Will see value in this product. Expecting US Government bonds to breakout.
All the names have been performing well. Improved profitability in 2023 sets the stage for continued growth going forward. Focusing on menu innovation and digital transformation through mobile apps. Franchise business model offers stability and good cashflow visibility. Track record of increasing dividends and share buybacks. Yield is 3.1%, expected to grow modestly over the next few years.
Chart shows ascending pattern of higher highs and higher lows, technically solid. Shares outpacing the TSX since mid-2022. Seeing a 9-10% earnings growth rate.
Shares down 16-17%, near 200-day MA, opportunity. Very strong brand reputation, dominant market position. Very consistent revenue growth. Short term, still sees pretty stable US housing market, consumer confidence remains stable. US labour market remains steady, with low unemployment. Interest rates will be lower at some point. Yield is 2.7%, very consistent dividend increases.
Homes are aging, shortage in home inventory, home prices still going higher. Very resilient during downturns, home maintenance needs continue regardless of what's going on.
Leader, controls 1/3 of the industry. Virtual triopoly gives them leverage and predictable cashflow. Population is aging. At least 60% of Americans use at least 1 drug, and this will increase over time. High-demand segments such as weight loss and diabetes are rising, which will increase demand for its logistics and distribution. Yield is 0.5%.
Increased share buybacks last summer. Beat top and bottom on last results. Upped guidance for 2024. Share price trending higher, above 200-day and 200-week MAs. Has beat S&P since early 2019. About 12% earnings growth rate. Classic, steady healthcare name to own.
AI is in its infancy, major driver of profitability. Has come down with the market, so at a relatively good level. Lots of upside on fundamentals and technicals. The price target is $132, but could go as high as $150. This type of name should perform well in this phase of the market. Yield is 0.4%.
(Analysts’ price target is $132.67)Priced to perfection. Stock came down from expectations, an entry point. Chance to buy one of the better names. Using AI to generate significantly more ad revenue. Could see a scenario where stock moves above all-time highs, proof will be in the pudding. Still needs good earnings, and will need to be careful of spending. Have to spend money to make money, and he feels they'll do well. Yield is 0.4%.
(Analysts’ price target is $526.83)A broad-based play. A lot of individual names go down 10-15% when they miss on earnings. This ETF gives you diverse exposure to the names you'd want to own, but wrapped up in a nice little package. Buy and hold for the next year, see where we are after that.
His thesis is that growth is going to outperform.
The Canadian equivalent is CHPS.
According to Brooke Thackray and The Weekly Buzzing Stocks by Billy Kawasaki, the best stocks to buy today are AAPL-Q, BA-N, T-N, XLV-N, XLU-N, HTB-T.
Excellent name that offers defensive protection. Strength in health care sector good for investors. Weakness in sector that past 1-2 years is creating buying opportunity.